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Methods:
 
 The study included 31 patients (57±14 years, 23 males) with
HCM and preserved LVEF (65±8%, range 50 to 79%) without significant LV
obstruction (<50mmHg) at rest. All underwent exercise testing and 2D and 3D
echocardiography. LV dyssynchrony defined by the 16 segment standard
deviation of time to peak longitudinal strain by speckle tracking (16SD) was
compared to exercise capacity, 3D myocardial mass and LV filling pressure
assessed by the ratio E/E’
 
TDI
 
 (Peak early filling velocity over peak systolic
velocity by TDI).
 
Results:
 
 LV dyssynchrony (16SD=96±35 ms) was associated to a reduced
exercise capacity (r=-0.39, p=0.035) and increased LV filling pressure (r=0.50,
p=0.01). Interestingly LV dyssynchrony increased with the severity of myo-
cardial hypertrophy (r=0.66, p<0.001) and was associated to a reduce global-
strain (r=0.62, p<0.001). 
 
Conclusion:
 
 Myocardial dyssynchrony increased with the severity of myo-
cardial hypertrophy in HCM patients and may be involved in exercise limita-
tion in patients without LV obstruction and preserved LVEF. 
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Background:
 
 Obesity has been described as an independent risk factor for
heart failure (HF). However, B-type natriuretic peptide (BNP) failed in evalua-
tion of the severity of HF in obese patient because: i) Obese patients suffer
dyspnoea earlier than non obese which leads to an earlier diagnosis an could
explain lower BNP rates, and ii) BNP receptors were found on adipocytes sug-
gesting a higher clearance of BNP in obese patients. 
 
Purpose:
 
 Our aim was to explore the relationship between functional status
of obese HF patients and BNP levels. 
 
Method and results:
 
 In our HF registry, 249 patients with dilated cardio-
myopathy (DCM) were included in 3 groups regarding their body mass index:
112 normal weighted <25 kg/m
 
2
 
 (NW), 88 overweighted 25-29.9 kg/m
 
2
 
 (OW),
and 49 obese 30 kg/m
 
2
 
 or greater (Ob) patients. We analyzed NYHA status,
the 6 minutes walk test (6MWT) a simple and reliable way to assess the exer-
cise capacity of DCM patients, and measured the peak oxygen consumption
during incremental exercise (VO2 max). 
There was no significant difference between the 3 groups for baseline cha-
racteristics and ejection fraction was comparable (NW: 27+/-9%; OW: 27+/-
9%; Ob: 29+/-10%; p=0.26))
BNP levels were lower in the obese group (962+/-1166 in NW, 757+/-204
in OW, 353+/-608 in Ob; p=0.02). There was no significant difference
between groups in distance covered in the 6MWT (NW: 370+/-98m; OW:
392+/-125m; Ob: 388m; p=0.27) and NYHA scores (NM: 2.3+/-0.7; OW:
2.3+/-0.6; Ob: 2.4+/-0.7; p=0.32), however, VO2 max was significantly lower
in the Ob patients (NW: 17.4+/-7.7 ml/min/kg; OW: 16.1+/-5.0 ml/min/kg;
Ob: 14.8+/-6.9ml/min/kg; p=0.04). 
 
Conclusion:
 
 These results show that VO2 max is more useful to discrimi-
nate functional status in obese patients with DCM compared to 6MWT,
NYHA scores and BNP levels. BNP in the obese likely underestimates seve-
rity of HF.
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Purpose:
 
 Heart rate adjustment of exercise-induced ST-segment depres-
sion (ST/HR index and ST/HR hysteresis) has been suggested as an accurate
predictor of the presence of a coronary artery disease. Its powerful predictive
value for proven coronary artery stenosis is now accepted. The objective of
our study was to investigate the sentitivity and specificity of computerized ST/
HR index and ST/HR hysteresis to detect significant ischemia. 
 
Methods: We used a cross-sectional analysis of exercise test and myocar-
dial perfusion stress-rest SPECT data. The study population comprised 710
consecutive patients referred for myocardial perfusion imaging. The threshold
of significant ischemia was set above 10% reversibility hypoperfusion area
from entire surface of left ventricle using gated -SPECT image analysis
(QGS). Diagnostic performance of ST/HR index and ST/HR hysteresis was
assessed by receiver operating characteristic (ROC) curve. 
Results: Crude ST/HR hysteresis showed at the same 70% specificity, a
sensitivities of 56% and 57%, respectively. Diagnostic performance of ST/HR
hysteresis seems slightly better than ST/HR index (AUC= .668 vs .654) with
the following cut points .038 mV and 1.625 µV/ bpm. Adjusting these varia-
bles to body mass index does not improve the diagnostic performance. Com-
bining an independant clinical judgement in the model yields a moderate
increase of the diagnostic accuracy the prediction only for ST/HR index as
suggested by the AUC (.688) . 
Conclusions: ST/HR index and ST/HR hysteresis have a good capability to
detect a significant myocardial ischemia evaluated by SPECT, which has the-
rapeutic implications. 
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Introduction: Heart failure (HF) remains a frequent reason for admission
and readmission to hospital and therefore represents a major public health
burden. The aim of our study is to report the experience of our therapeutic unit
of heart failure (TUHF), the epidemiological profile, the management and the
outcome of 1200 patients with chronic heart failure (CHF).
Material and methods: The study included 1200 patients, admitted in the
TUHF from May 2006 to February 2010. We included all patients with (CHF)
symptomatic class II, III, or IV. All patients were evaluated clinically with
monitoring of blood pressure , 6 min walk test and electrocardiogram. Two-
dimensional echocardiography and laboratory tests were performed in all
patients. 
Results: The mean age of our patients was 64.82±12.14 years (16-100),
75% were men. Hypertension was the most frequently cardiovascular risk
factor (26%) followed by smoking (22%) and diabetes (21%). Patients were
mainly in NYHA class II ( 58%), and 27% were in NYHA class III. The ave-
rage of 6 minute walk test was 121.36 ±92.74 m (10 – 630 ). The mean heart
rate at admission was 81.13 ± 17.24 bpm. More than half of our patients had
an LVEF <35% (56.91%), 31.33% had LVEF between 35-50%, and 6.33%
had an LVEF> 50%. Ischemic (55.67%) and hypertensive heart disease
(2.67%) remain the two most frequent etiology. 
Regarding treatment; 78.33% of our patients were treated with beta-blockers,
89.08%with Angiotensin-converting enzyme inhibitors (ACEI), 50.75% with
spironolactone , and 12.75% with diuretics. Resynchronization has been per-
formed in two patients. 
The optimal medical treatment has allowed a significant improvement in
NYHA functional class: NYHA class II (20% vs. 58%, P= 0.037), NYHA
class III (5% vs 27%, P= 0.002), a significant improvement in test 6min walk
( 121.36 vs 465.66 m, P= 0.0001), and a significant reduction in heart rate
from 80.13 bpm to 63.12bpm (P< 0.05) on an average of 6.82± 4.18 months.
Conclusion: The creating of TUHF in our department has allowed an
improving of the quality of care and an optimization of the treatment.
